Effects of sustained-release isradipine on blood pressure and peripheral hemodynamics in hypertensive patients.
Arosio E, Pancera P, Priante F, +3 more·Clinical therapeutics
In a double-blind crossover study, 16 hypertensive patients (mean age, 41 years) were randomly assigned to receive placebo or 5 mg of an extended-release formulation of isradipine for 30 days. Blood pressure and heart rate were recorded by an automatic device and hemodynamics measured by a duplex scanner and plethysmog…